Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship: Priority Announcement - Kidney Disease

Direct Payment

$75,000.00

Investigation of metabolic pathways in Renal Cell Carcinoma

FY 2016-17

Summary
Kidney cancer is a major contributor to the burden of cancer and chronic disease in Canada, with an estimated 6400 individuals diagnosed in 2016. While cigarette smoking is a known risk factor, studies have shown that lifestyle factors, such as obesity, hypertension and nutrition, may have a bigger impact on kidney cancer risk. However, the biological mechanisms through which these risk factors operate remain unclear. Metabolites are small molecules that can be measured in blood, and can provide information about the impact of environmental and genetic factors on biochemical processes inside our cells. Our main goal is to investigate metabolites and identify unique chemical fingerprints associated with kidney cancer risk factors. This work will provide a deeper understanding of the metabolic processes by which obesity, hypertension and other related conditions, as well as B-vitamins, influence kidney cancer risk. We will measure metabolite levels in blood samples, obtained from kidney cancer patients up to 15 years before diagnosis, and compare them to concentrations observed in cancer-free individuals. This will allow us to identify metabolites linked to disease risk. Next, we will evaluate whether these metabolites can explain the mechanisms by which known risk factors lead to kidney cancer development. We will also investigate metabolic profiles, to provide insight into broader disease pathways and mechanisms. Finally, we will identify genetic variants linked to specific metabolites, and examine how these relate to kidney cancer risk. This work represents an important advance over previous studies, which were conducted on a smaller scale, and only investigated metabolic profiles after cancer diagnosis. As the number of individuals affected by kidney cancer increases, it is important to understand why and how lifestyle factors related to metabolism increase risk, in order to develop more effective strategies for kidney cancer prevention and early detection.
Program
Fellowship: Priority Announcement - Kidney Disease
Location
France
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
363826
Name
Kachuri Mirlinda
Country
France
Orgtype
Research Institution
Partnername
Kidney Foundation of Canada
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigation of metabolic pathways in Renal Cell Carcinoma
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Fellowship: Priority Announcement - Kidney Disease
Keyworddelim
Genetics And Genomics; Kidney Disease; Metabolic Syndrome; Metabolomics; Nutrition And Obesity; Renal Cell Carcinoma
Abstract
Kidney cancer is a major contributor to the burden of cancer and chronic disease in Canada, with an estimated 6400 individuals diagnosed in 2016. While cigarette smoking is a known risk factor, studies have shown that lifestyle factors, such as obesity, hypertension and nutrition, may have a bigger impact on kidney cancer risk. However, the biological mechanisms through which these risk factors operate remain unclear. Metabolites are small molecules that can be measured in blood, and can provide information about the impact of environmental and genetic factors on biochemical processes inside our cells. Our main goal is to investigate metabolites and identify unique chemical fingerprints associated with kidney cancer risk factors. This work will provide a deeper understanding of the metabolic processes by which obesity, hypertension and other related conditions, as well as B-vitamins, influence kidney cancer risk. We will measure metabolite levels in blood samples, obtained from kidney cancer patients up to 15 years before diagnosis, and compare them to concentrations observed in cancer-free individuals. This will allow us to identify metabolites linked to disease risk. Next, we will evaluate whether these metabolites can explain the mechanisms by which known risk factors lead to kidney cancer development. We will also investigate metabolic profiles, to provide insight into broader disease pathways and mechanisms. Finally, we will identify genetic variants linked to specific metabolites, and examine how these relate to kidney cancer risk. This work represents an important advance over previous studies, which were conducted on a smaller scale, and only investigated metabolic profiles after cancer diagnosis. As the number of individuals affected by kidney cancer increases, it is important to understand why and how lifestyle factors related to metabolism increase risk, in order to develop more effective strategies for kidney cancer prevention and early detection.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kachuri, Mirlinda
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $75,000~ $0~
Direct Payment - $75,000 Grant (2016-17) | Canada Spends